Education
About Us
Working with TipRanks
Follow Us
Carl Gordon Insider Profile
39 Followers
Carl Gordon, Director at Intellia Therapeutics, holds ― shares in Intellia Therapeutics (Ticker: NTLA), holds 1.02M shares in Keros Therapeutics (Ticker: KROS), holds 15.22M shares in Compass Therapeutics (Ticker: CMPX). Most recently, Carl Gordon ― shares of Intellia Therapeutics on ― for an estimated value of ―.
Profitable Transactions
12 out of 28 Profitable Transactions
Average Return
-3.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Carl Gordon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 13, 2020 - Apr 13, 2021
Return:+175.70%
The most profitable trade made by Carl Gordon
Carl Gordon's Trading History
Intellia Therapeutics
―
Director
―
―
X4 Pharmaceuticals
Nov 20, 2017
Director
Uninformative Buy
―
$5.92M
Armo Biosciences Inc
Jun 22, 2018
―
Uninformative Sell
205.95M
$0.00
Alector
Feb 11, 2019
Director, Ten Percent Owner
Uninformative Buy
―
$615.70K
Turning Point Therapeutics
Apr 24, 2019
―
Uninformative Buy
―
$154.11M
Prevail Therapeutics
Jun 26, 2019
―
Uninformative Buy
―
$317.92M
Keros Therapeutics
Jun 06, 2025
Director
Uninformative Buy
―
$15.93M
Oric Pharmaceuticals
Mar 31, 2021
Director, Ten Percent Owner
Uninformative Sell
2.43M
$23.36M
Adicet Bio
Jun 07, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$9.10M
Kinnate Biopharma
Apr 05, 2024
―
Uninformative Sell
―
$0.00
Terns Pharmaceuticals
Jul 17, 2024
Director, Ten Percent Owner
Informative Sell
561.64K
$5.69M
Disc Medicine
―
Director, Ten Percent Owner
―
―
Theseus Pharmaceuticals
Feb 14, 2024
―
Uninformative Sell
―
$0.00
Compass Therapeutics
Apr 11, 2025
Director, Ten Percent Owner
Informative Sell
5.68M
$51.60M
ArriVent BioPharma, Inc.
Jan 31, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$26.72M
MBX Biosciences, Inc.
Feb 19, 2025
Director, Ten Percent Owner
Informative Buy
2.02M
$7.48M
Pacira Pharmaceuticals
Feb 10, 2011
Director
Informative Buy
13.33M
$75.42M
ACADIA Pharmaceuticals
―
Director
―
$34.08M
Acceleron Pharma
Sep 18, 2013
―
Uninformative Buy
―
$1.43M
Amarin
Sep 05, 2012
Director
Uninformative Sell
3.37M
$87.50K
BioCryst
―
Director
―
$0.00
Complete Genomics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Carl Gordon's performance on stock
You May Also Like
Carl Gordon insider profile FAQ
What is the percentage of profitable transactions made by Carl Gordon?
The percentage of profitable transactions made by Carl Gordon is 43%.
What is the average return per transaction made by Carl Gordon?
The average return per transaction made by Carl Gordon is -3.80%.
What stocks does Carl Gordon hold?
Carl Gordon holds: NTLA, XFOR, ARMO, ALEC, TPTX, PRVL, KROS, ORIC, ACET, KNTE, TERN, IRON, THRX, CMPX, AVBP, MBX, PCRX, ACAD, XLRN, AMRN, BCRX, ~GNOM stocks.
What was Carl Gordon’s latest transaction?
Carl Gordon latest transaction was an Uninformative Buy of ―.
What was Carl Gordon's most profitable transaction?
Carl Gordon’s most profitable transaction was an Informative Buy of KROS stock on April 13, 2020. The return on the trade was 175.70%.
What is Carl Gordon's role in Intellia Therapeutics?
Carl Gordon's role in Intellia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.